Electromagnetic Cell Current Modulation As Adjunctive Therapy in HIV: A Review

Area of Science:

• Immunology
• Biophysics
• Infectious Diseases

Background:

• Antiretroviral therapy (ART) for HIV has limitations, including chronic immune activation and latent reservoirs.
• Current treatments do not fully restore immune function or achieve a cure.
• There is a need for adjunctive therapies targeting host-level dysfunctions in HIV.

Purpose of the Study:

• To critically evaluate Electromagnetic Cell Current Modulation (ECCM) as a potential adjunctive therapy for HIV.
• To integrate mechanistic, preclinical, and early clinical evidence for ECCM in HIV.
• To assess ECCM's potential to address persistent challenges in HIV management.

Main Methods:

• Narrative synthesis of existing research on ECCM in HIV.
• Inclusion of studies from cellular, animal, and early patient-level investigations.
• Comparison of ECCM with other adjunctive treatment modalities.

Main Results:

• ECCM may modulate cytokine signaling and reduce inflammation.
• Evidence suggests ECCM can enhance mitochondrial activity and potentially impact viral latency.
• Pilot studies indicate improvements in CD4 counts, symptom burden, and quality of life.

Conclusions:

• ECCM presents a scientifically plausible adjunctive strategy for HIV, targeting host-level dysfunctions.
• Validated ECCM could complement ART by addressing immune restoration gaps.
• Rigorous clinical trials and standardized protocols are essential to establish ECCM's safety and efficacy.